Trial · NCT03612401
Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron
NCT03612401, Early phase 1, Completed, The University of Texas Health Science Center at San Antonio
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron. Trials, record NCT03612401. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03612401
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron
- NCT number
- NCT03612401
- Status
- Completed
- Phases
- Early phase 1
- Enrollment
- 20 participants, actual
- Lead sponsor
- The University of Texas Health Science Center at San Antonio
- Conditions
- Spinal Cord Injuries, Neurogenic Bladder, Cognitive Change
- Interventions
- Mirabegron
- First posted
- 2018-08-02
- Last updated
- 2021-06-22
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in cognitive measure - Logical Memory I (Immediate) - baseline and post treatment with mirabegron | Change from Week 0 to Week 26 | Wechsler Memory Scale, 4th edition (WMS-IV) subtest |
| Secondary | Change in cognitive measure of memory (SLUMS) - baseline and post treatment with mirabegron | Change from Week 0 to Week 26 | Saint Louis University Mental Status Exam (SLUMS) - a series of shapes and recall measures |
| Secondary | Change in cognitive measure of executive function (Stroop test) - baseline and post treatment with mirabegron | Change from Week 0 to Week 26 | Stroop Color and Word Test - a series of color-word and picture-word tests of executive function |
| Secondary | Change in cognitive measure of executive function (SDMT) - baseline and post treatment with mirabegron | Change from Week 0 to Week 26 | Symbol Digit Modalities Test - a series of symbols to assess executive function |
| Secondary | Change in memory and executive function (TEXAS) - baseline and post treatment with mirabegron | Change from Week 0 to Week 26 | Texas Executive Assessment (TEXAS) - A series of short term recall measures |
| Secondary | Change in Neurogenic Bladder Symptom Score (NBSS) - baseline and post treatment with mirabegron | Change from Week 0 to Week 26 | Neurogenic bladder symptom questionnaire |
| Secondary | Change in Neurogenic Bowel Dysfunction Score (NBD) - baseline and post treatment with mirabegron | Change from Week 0 to Week 26 | Neurogenic bowel questionnaire |
| Secondary | Change in cognitive measure - Logical Memory II (Delayed) - baseline and post treatment with mirabegron | Change from Week 0 to Week 26 | Wechsler Memory Scale, 4th edition (WMS-IV) subtest |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests3
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Short Story Recall | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Symbol Coding | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03612401
GET https://conductscience.org/api/trials/v1/NCT03612401/registered